BioSpace News Archive

Capillary electrophoresis, which enables Sanger sequencing and fragment analysis, is an important tool for improving clinical research and advancing scientific discovery.

Carestream Health’s groundbreaking Smart Noise Cancellation (SNC) technology has received FDA 510(k) Clearance for its dose reduction capability.

In connection with its virtual business review, Amgen (NASDAQ:AMGN) provided preliminary long-term guidance between 2022 and 2030 in addition to full year 2022 guidance.

Expression Therapeutics, Inc. announced that Chief Executive Officer, Dr. Mohan Rao, was selected to present at the BIO CEO & Investor Conference in New York City from February 14-16 and participate in one-on-one investor meetings.

Blackrock Neurotech, the leader in brain-computer interface technology, has signed an exclusive license for Columbia University’s neural decoder MINT.

Evolus Receives Acceptance of Submission in Australia, a Pivotal Step in Approval Process for Nuceiva ® .

Trinity Life Sciences, a leader in global life sciences solutions, conducted research to explore the importance and impact of Competitive Intelligence (CI) from the perspective of pharma clinical and commercial teams.

Pulse Biosciences, Inc. today announced an update to its recent U.S. Food and Drug Administration (FDA) 510(k) submission to add the specific indication for treatment of sebaceous hyperplasia to expand the CellFX System’s current labeling.

Techdow USA Inc. (“Techdow USA”), a vertically integrated generic injectables company, today announced the launch of its Heparin Sodium Injection, USP in the US market.

Echosens, a high-technology company offering the FibroScan® portfolio of solutions, is pleased to announce that the latest Baveno VII guidelines fully support the effectiveness of FibroScan technologies for the management of patients with advanced chronic liver disease, providing a powerful level of support for its use among specialists.